Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Total Liabilities (Quarterly): 81.97M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 81.97M |
| September 30, 2023 | 62.78M |
| June 30, 2023 | 52.54M |
| March 31, 2023 | 28.03M |
| December 31, 2022 | 37.10M |
| September 30, 2022 | 44.46M |
| June 30, 2022 | 28.15M |
| March 31, 2022 | 20.79M |
| December 31, 2021 | 25.64M |
| September 30, 2021 | 21.77M |
| June 30, 2021 | 16.85M |
| Date | Value |
|---|---|
| March 31, 2021 | 8.35M |
| December 31, 2020 | 8.694M |
| September 30, 2020 | 7.177M |
| June 30, 2020 | 6.013M |
| March 31, 2020 | 4.777M |
| December 31, 2019 | 3.108M |
| September 30, 2019 | 1.697M |
| June 30, 2019 | 126.35M |
| March 31, 2019 | 124.16M |
| December 31, 2018 | 45.78M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.697M
Minimum
Sep 2019
126.35M
Maximum
Jun 2019
30.85M
Average
21.77M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 82.48B |
| RayzeBio inc (DELISTED) | 28.19M |
| Icosavax Inc (DELISTED) | 18.92M |
| Madrigal Pharmaceuticals Inc | 235.21M |
| Theseus Pharmaceuticals Inc (DELISTED) | 10.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.336B |
| Shareholders Equity (Quarterly) | 1.254B |